Charles River Laboratories International, Inc.

NYSE:CRL Rapporto sulle azioni

Cap. di mercato: US$9.2b

Charles River Laboratories International Salute del bilancio

Salute finanziaria criteri di controllo 4/6

Charles River Laboratories International ha un patrimonio netto totale di $3.8B e un debito totale di $2.4B, che porta il suo rapporto debito/patrimonio netto a 63.2%. Le sue attività totali e le sue passività totali sono rispettivamente $7.9B e $4.2B. L'EBIT di Charles River Laboratories International è $628.1M rendendo il suo rapporto di copertura degli interessi 5. Ha liquidità e investimenti a breve termine pari a $179.2M.

Informazioni chiave

63.2%

Rapporto debito/patrimonio netto

US$2.38b

Debito

Indice di copertura degli interessi5x
ContantiUS$179.21m
Patrimonio nettoUS$3.77b
Totale passivitàUS$4.18b
Totale attivitàUS$7.95b

Aggiornamenti recenti sulla salute finanziaria

Recent updates

Charles River Laboratories International (NYSE:CRL) Has A Somewhat Strained Balance Sheet

Oct 26
Charles River Laboratories International (NYSE:CRL) Has A Somewhat Strained Balance Sheet

What Charles River Laboratories International, Inc.'s (NYSE:CRL) P/E Is Not Telling You

Oct 11
What Charles River Laboratories International, Inc.'s (NYSE:CRL) P/E Is Not Telling You

Why Charles River Laboratories International, Inc. (NYSE:CRL) Could Be Worth Watching

Sep 10
Why Charles River Laboratories International, Inc. (NYSE:CRL) Could Be Worth Watching

US$227: That's What Analysts Think Charles River Laboratories International, Inc. (NYSE:CRL) Is Worth After Its Latest Results

Aug 10
US$227: That's What Analysts Think Charles River Laboratories International, Inc. (NYSE:CRL) Is Worth After Its Latest Results

Charles River Laboratories: Q2, Cost Structure Streamlining (Rating Upgrade)

Aug 10

Charles River Laboratories International (NYSE:CRL) Takes On Some Risk With Its Use Of Debt

Jul 26
Charles River Laboratories International (NYSE:CRL) Takes On Some Risk With Its Use Of Debt

Risks To Shareholder Returns Are Elevated At These Prices For Charles River Laboratories International, Inc. (NYSE:CRL)

Jul 11
Risks To Shareholder Returns Are Elevated At These Prices For Charles River Laboratories International, Inc. (NYSE:CRL)

Charles River Laboratories: Fair Valuation Against Fundamentals

May 31

What Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Doing?

May 25
What Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Doing?

Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 30% Discount?

Apr 27
Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 30% Discount?

Charles River Laboratories International, Inc.'s (NYSE:CRL) Price Is Out Of Tune With Earnings

Apr 11
Charles River Laboratories International, Inc.'s (NYSE:CRL) Price Is Out Of Tune With Earnings

Charles River Laboratories International (NYSE:CRL) Has A Pretty Healthy Balance Sheet

Mar 27
Charles River Laboratories International (NYSE:CRL) Has A Pretty Healthy Balance Sheet

Charles River Laboratories International (NYSE:CRL) Strong Profits May Be Masking Some Underlying Issues

Feb 21
Charles River Laboratories International (NYSE:CRL) Strong Profits May Be Masking Some Underlying Issues

Charles River Laboratories: Weak Biopharma Spending Is Transitory; Initiate With 'Hold'

Feb 16

Is It Time To Consider Buying Charles River Laboratories International, Inc. (NYSE:CRL)?

Jan 17
Is It Time To Consider Buying Charles River Laboratories International, Inc. (NYSE:CRL)?

Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Not Quite Adding Up

Jan 02
Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Not Quite Adding Up

Charles River Laboratories International (NYSE:CRL) Ticks All The Boxes When It Comes To Earnings Growth

Dec 17
Charles River Laboratories International (NYSE:CRL) Ticks All The Boxes When It Comes To Earnings Growth

Charles River Laboratories: Mr. Market Went From Overvaluation To Undervaluation

Nov 26

Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 29% Discount?

Nov 12
Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 29% Discount?

Charles River: Q3 Points To Ongoing Deterioration

Nov 09

Charles River Laboratories International (NYSE:CRL) Has A Somewhat Strained Balance Sheet

Oct 27
Charles River Laboratories International (NYSE:CRL) Has A Somewhat Strained Balance Sheet

At US$197, Is Charles River Laboratories International, Inc. (NYSE:CRL) Worth Looking At Closely?

Oct 12
At US$197, Is Charles River Laboratories International, Inc. (NYSE:CRL) Worth Looking At Closely?

Charles River Laboratories: Diving Into The Lab (Rating Upgrade)

Oct 06

Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 27% Discount?

Aug 10
Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 27% Discount?

Charles River Laboratories: Very Attractive After The Pullback

Jul 26

Does Charles River Laboratories International (NYSE:CRL) Deserve A Spot On Your Watchlist?

Jul 22
Does Charles River Laboratories International (NYSE:CRL) Deserve A Spot On Your Watchlist?

Charles River Laboratories International (NYSE:CRL) Seems To Use Debt Quite Sensibly

Jul 03
Charles River Laboratories International (NYSE:CRL) Seems To Use Debt Quite Sensibly

When Should You Buy Charles River Laboratories International, Inc. (NYSE:CRL)?

Jun 19
When Should You Buy Charles River Laboratories International, Inc. (NYSE:CRL)?

A Look At The Intrinsic Value Of Charles River Laboratories International, Inc. (NYSE:CRL)

May 01
A Look At The Intrinsic Value Of Charles River Laboratories International, Inc. (NYSE:CRL)

Should You Be Adding Charles River Laboratories International (NYSE:CRL) To Your Watchlist Today?

Apr 16
Should You Be Adding Charles River Laboratories International (NYSE:CRL) To Your Watchlist Today?

These 4 Measures Indicate That Charles River Laboratories International (NYSE:CRL) Is Using Debt Reasonably Well

Apr 02
These 4 Measures Indicate That Charles River Laboratories International (NYSE:CRL) Is Using Debt Reasonably Well

Is Charles River Laboratories International, Inc. (NYSE:CRL) Potentially Undervalued?

Mar 19
Is Charles River Laboratories International, Inc. (NYSE:CRL) Potentially Undervalued?

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( $1.5B ) di CRL superano le sue passività a breve termine ( $947.5M ).

Passività a lungo termine: Le attività a breve termine di CRL ( $1.5B ) non coprono le sue passività a lungo termine ( $3.2B ).


Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: Il rapporto debito netto/patrimonio netto ( 58.4% ) di CRL è considerato alto.

Riduzione del debito: Il rapporto debito/patrimonio netto di CRL si è ridotto da 138.1% a 63.2% negli ultimi 5 anni.

Copertura del debito: Il debito di CRL è ben coperto dal flusso di cassa operativo ( 31.5% ).

Copertura degli interessi: I pagamenti degli interessi sul debito di CRL sono ben coperti dall'EBIT ( 5 x copertura).


Bilancio


Scoprire le aziende sane